J Dig Cancer Rep.  2019 Jun;7(1):5-7. 10.0000/jdcr.2019.7.1.5.

Adjuvant Therapy of Pancreatic Cancer

Affiliations
  • 1Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. whpaik@snuh.org

Abstract

Pancreatic cancer is a lethal disease since curative resection is available in only 20% of patients at the initial diagnosis. Even after radical resection of the cancer, most patients experience recurrence. Therefore, many clinical trials have been attempted to prevent recurrence of pancreatic cancer. The key clinical studies about adjuvant therapy of pancreatic cancer and currently available regimens in Korea will be reviewed concisely according to the chemotherapy, radiation therapy, or both.

Keyword

Pancreatic cancer; Adjuvant therapy; FOLFIRINOX; Recurrence
Full Text Links
  • JDCR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr